Anthropic's Q2 Revenue Trajectory and First Operating Profit Signal October IPO Is Moving From Plan to Execution

The S-1 is filed. That’s settled. The question now is what the numbers behind it actually say.

Anthropic confirmed on June 1 that it had confidentially submitted a draft registration statement to the Securities and Exchange Commission under JOBS Act provisions, a procedural step that keeps the document private until the company chooses to go public. “This gives us the option to go public after the SEC completes its review,” the company stated, per CNBC’s reporting. It’s an option, not a commitment. But the financial trajectory described since the filing makes the option look increasingly likely to be exercised.

WSJ reported that Anthropic is projected to generate approximately $10.9 billion in net revenue in Q2 2026, and that this quarter is expected to mark the company’s first-ever operating profit. The specific profit figure circulating in some analyses hasn’t been independently confirmed; what WSJ confirms is the direction. A company that wasn’t covering its costs is now crossing into the black, in the same quarter it filed for IPO.

That timing matters. Investors pricing a frontier lab IPO want to buy into a growth story, not a subsidy story. Operating profitability, even marginal, even first-time, reframes the Anthropic narrative from “expensive AI bets” to “AI infrastructure that pays.” It doesn’t guarantee a successful listing, but it changes the terms of the conversation.

The revenue picture carries a distinction worth keeping in mind. Anthropic has reported an annualized revenue run-rate of $47 billion, a company-reported metric based on its most recent revenue pace, annualized forward. WSJ’s $10.9 billion figure is an estimated net revenue figure for a single quarter. The hub covered this gap in May: ARR and net revenue measure different things, and both numbers are technically accurate in their own context. The $47B figure has been Anthropic’s preferred metric; WSJ’s $10.9B is the closer approximation of what a public company’s income statement would show. Enterprise buyers and investors should be working from the latter.

On the underwriting side, Goldman Sachs, JPMorgan, and Morgan Stanley are reportedly in active discussion as underwriting advisors, per reports, though none of the three banks or Anthropic have confirmed this publicly. The same three names led OpenAI’s underwriting process, per prior registry coverage. If confirmed, the team composition would signal top-tier institutional support for the offering.

Anthropic is reportedly targeting a Nasdaq listing as early as October 2026, pending SEC review and market conditions. That’s a roughly four-month window, which is tight but not unusual for a company entering the review process with clean financials and strong institutional interest.

This is the third frontier lab moving toward public markets simultaneously. xAI’s investor roadshow reportedly starts June 8; OpenAI’s IPO timeline is documented in prior hub coverage. The competitive dynamics of all three listing in proximity are worth tracking separately. For Anthropic specifically: watch the SEC’s review timeline, any amendment to the S-1 that makes the filing public, and Q2 earnings confirmation as the first real test of whether the $10.9B projection holds.

The real story isn’t the filing. It’s that Anthropic is entering the public market runway with profitability timing it almost certainly didn’t have twelve months ago. The Series H closed at a $965B post-money valuation. If Q2 confirms operating profit at $10.9B quarterly revenue, the IPO pricing conversation starts from a very different floor. Watch the first public S-1 amendment, that’s when the numbers stop being projections.